High Throughput Screening Market 2030: Implications for Personalized Medicine
The global high throughput screening market size is expected to reach USD 41.67 billion by 2030, registering a CAGR of 10.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of faster and accurate technology by pharmaceutical companies to introduce newer molecules in the market is anticipated to provide a significant push to the market.
High throughput screening is used for testing of molecules in development phase on various grounds such as chemical, pharmaceutical, and genetic reactions. These screenings help in drug design and development based on real-time results and near-natural conditions that mimic natural reactions between the molecule and the body.
Gather more insights about the market drivers, restrains and growth of the High Throughput Screening Market
Moreover, this method can be fully automated using the required hardware and software capable of handling a fully automated process along with data storage units that store and process a considerable amount of data in a short span of time.
As of 2016, approximately 55.0% of high throughput screening tests are carried out based on the cell-based assays. Cell-based assays are used majorly owing to the results that can be obtained at cellular levels along with pathways and mechanisms.
These assays range from cytotoxic tests, including apoptosis, to cell metabolic assays. One more major technology implantation is the introduction of 3D - cell culture, which can help mimic natural conditions that give more accurate results and reactions to tests carried on. This trend is estimated to support the growth of the market during the forecast period.
High Throughput Screening Market Report Highlights
- The market is driven by increasing competition between pharmaceutical companies to introduce novel molecules
- Emerging 3D cell culture technology that provides better results in real-time is set to boost the market
- North America emerged as the clear hotspot for the development and adoption of this technology and had a major share in the market
- Emerging regions such as Asia Pacific and Latin America are set to witness considerable growth in demand over the forecast period driven by the need of newer molecules to cure various diseases
Browse more reports published by Grand View Research.
- Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments), By Grade (Molecular Grade, Transfection Grade), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2024 - 2030
List of Key Players in the High Throughput Screening Market
- Agilent Technologies, Inc.
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc
- Aurora Biomed Inc.
- Tecan Trading AG
- Promega Corporation
- Charles River Laboratories.
- Creative Biolabs
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Explore Horizon, the world's most expansive market research database
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian